Stifel Reiterates Buy Rating for Astera Labs, Inc. (ALAB)
Stifel maintains a buy rating for Astera Labs, Inc. with a $460 price target, a 21.37% upside from the current price.
Key Points
- Stifel reiterated its buy rating on Astera Labs, Inc. (ALAB) with a price target of $460 on June 24, 2026.
- Stifel's $460 price target implies 21.37% upside from Astera Labs, Inc.'s ($ALAB) current $379 share price.
- Astera Labs, Inc. traded at $401.46 on Wednesday, with a market cap of $75.36 billion and a P/E ratio of 301.1.
- FMR LLC, BlackRock, Inc., and Vanguard Capital Management LLC made notable changes in their holdings of Astera Labs.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Stifel reiterated its buy rating on Astera Labs, Inc. (NasdaqGS: ALAB) on June 24, 2026. The firm set a price target of $460, indicating continued confidence in the semiconductor company's prospects. Shares of Astera Labs traded at $401.46 on Wednesday.
Stifel vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Other Institutional Activity in Astera Labs, Inc.
FMR LLC increased its holdings in Astera Labs by 194,944 shares, bringing its total to over 25.5 million shares valued at approximately $2.8 billion. BlackRock, Inc. reduced its position by 1,519,089 shares, leaving it with 11.4 million shares worth about $1.25 billion. Vanguard Portfolio Management LLC opened a new position with 7,309,778 shares valued at $801.2 million. Similarly, Vanguard Capital Management LLC also initiated a stake with 6,340,732 shares valued at $694.9 million. Atreides Management, LP significantly boosted its stake by 1,754,593 shares, now holding 3,365,787 shares valued at $368.9 million.
Astera Labs, Inc. Stock Up 30.9%
As of Wednesday, Astera Labs' stock was trading near $401.46. The company, with a market cap of $75.36 billion, has a P/E ratio of 301.1 and a forward P/E of 104.5. The stock's beta is 3.963, indicating higher volatility. Over the past year, the stock has ranged from a low of $84.78 to a high of $440.99, with a 50-day moving average of $258.03 and a 200-day moving average of $186.22. Astera Labs maintains a strong financial position with a current ratio of 11.3 and a quick ratio of 10.55.
$ALAB price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Recent Earnings
Astera Labs reported revenue of approximately $1 billion with a robust growth rate of 93.4%. The company achieved a net margin of 26.7% and a return on equity of 21.1%. Earnings per share stood at $1.46. The next earnings release is scheduled for August 4, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
10 analysts raised price targets.
-
EPS & revenue
EPS beat estimates by 11.6%. Revenue beat estimates by 3.5%.
-
Profit surprise
EBITDA missed by 34 percent. Operating income missed by 40 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
10 target raises.
-
Earnings quality
Gross margin up 1.4 points. Operating margin up 13.0 points.
Earnings Call Summary
Astera Labs delivered strong Q1 results with revenue of $308 million, up 93 percent year over year, driven by broad growth across signal conditioning and fabric switch products. PCIe Gen 6 products contributed over one third of total revenue. The company shipped initial production volumes of the new Scorpio X 320-lane switch and is expanding optical capabilities through the XScale acquisition, with near-package optics expected to ship in 2027 and chiplet-package optics in 2028.
Guidance Management expects revenue between $355 million and $365 million in the next quarter, up 15 to 18 percent sequentially. They expect non-GAAP earnings per share between $0.68 and $0.70, with gross margin around 73 percent before a one-time customer agreement charge. The Scorpio product line is expected to become their largest business by year end.
Slightly positive report. The quarter was acceptable, but the forward setup is not strong.
Insider Buying and Selling at Astera Labs, Inc.
On June 4, 2026, insider Jack Lazar sold 10,000 shares at an average price of $355.17 in a planned transaction. On the same day, several insiders, including Craig Barratt, Michael Hurlston, Bethany Mayer, Jack Lazar, and Stefan Dyckerhoff, each acquired 837 shares as part of non-planned transactions.
Analysts Set New Price Targets
On June 24, 2026, Stifel maintained its buy rating on Astera Labs with a $460 price target. On June 23, 2026, B of A Securities also maintained a hold rating with a $450 price target. Earlier in May, Evercore ISI Group reiterated a buy rating with a $297 target, while Barclays held a rating with a $200 target. The consensus recommendation for Astera Labs is a buy, with a mean target price of $244.97 based on 22 analyst opinions.
About Astera Labs, Inc.
Astera Labs, Inc. is a technology company specializing in semiconductor-based connectivity solutions for cloud and AI infrastructure. Based in San Jose, California, the company was founded in 2017 and is led by CEO Mr. Jitendra Mohan. Astera Labs designs and manufactures high-speed connectivity products and offers software solutions for managing large-scale cloud resources. With 756 employees, the company provides products and services to hyperscalers and OEMs in the United States and Taiwan.
Bottom Line
Astera Labs, Inc. continues to attract analyst attention with Stifel's reiterated buy rating and a $460 price target. The company shows strong financial health and growth potential, backed by its innovative semiconductor solutions. Institutional investors have made significant moves in their holdings, reflecting varied strategies and outlooks on the company's future. As always, note that analyst ratings and 13F filings are backward-looking and may not indicate current conditions.
Get Astera Labs, Inc. alerts
New 13F filings, insider trades, and analyst moves on $ALAB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.